Investor Relations
Complete overview of the company's information
Corporate Governance
Chairman
Roberto AnzanelloCEO
Livia FogliaBoard Member
Oscar Pischeddu Diego FacchiniIndependent Board Member
Chiara Fisichella Paolo Polidoro Andrea Di DioChairman
Massimo D'AgostinoStanding Auditor
Paolo LombardoStanding Auditor
Agostino GaldiAlternate Auditor
Francesco TomasiAlternate Auditor
Luigi Borrelli
Sustainability
Information for shareholders
Year | N. of Shares | Nominal Value | Share Capital | Dividend Unit | Monte Dividendi | Exchange |
---|---|---|---|---|---|---|
2022 | 18.978.097 | € 1,00 | € 18.978.097,00 | N.A. | N.A. | Mercato Euronext Growth Milan |
2021 | 18.978.097 | € 1,00 | € 18.978.097,00 | N.A. | N.A. | Mercato Euronext Growth Milan |
2020 | 18.978.097 | € 1,00 | € 18.978.097,00 | N.A. | N.A. | Mercato AIM |
2019 | 14.324.956 | € 1,00 | € 14.324.956,00 | An ordinary share for every 100 shares and € 0.025 for each ordinary share | € 354.552 e n. 141.820 ordinary shares | Mercato AIM |
2018 | 14.324.956 | € 1,00 | € 14.324.956,00 | € 0,082 | € 1.173.808,00 | Mercato AIM |
2017 | 12.371.530 | € 1,00 | € 12.371.530,00 | € 0,081 | € 1.001.266,00 | Mercato AIM |
2016 | 11.245.580 | € 1,00 | € 11.245.580,00 | 0,00€ | 0,00€ | Unlisted |
Shareholding | Number of shares | % Share of ordinary capital |
---|---|---|
Sorgiva Holding S.p.A. | 4.739.080 | 24,97 % |
Mutua MBA Società di Mutuo Soccorso SCpA | 2.390.914 | 12,60 % |
PFH S.r.l. | 1.778.686 | 9,37 % |
Amara Life Holdings Ltd | 1.209.983 | 6,38 % |
Own actions * | 152.110 | 0,80 % |
Market ** | 8.707.324 | 45,88 % |
** of which 11.93% of the share capital held by non-significant shareholders who signed the shareholders' agreement announced with a press release dated 8 April 2022, which is not a float.
Updated on 31.10.2023.
From 1th July 2019 Health Italia stocks are negotiable with a minimum units lot.
There is no record of other shareholders apart from those listed above owning a share in the capital exceeding 5% that have notified Consob and Health Italia S.p.A. pursuant to art. 117 of Consob Regulation no. 11971/99 concerning the notification obligations for the relevant holdings.
Health Italia has met the requirements for the qualification of issuer with financial instruments distributed between the public to a significant extent pursuant to art. 2-bis of Consob Regulation no. 11971 of 1999. This qualification is effective starting from the 2020 financial year.
- the identity of the Significant Shareholders involved;
- the date on which Health Italia S.p.A. has been informed;
- the date on which the Substantial Change of the investments took place;
- the nature and extent of the participation of the Significant Shareholder in the transaction.
Internal Dealing Year 2022
2023th Documents
- Minutes of ordinary shareholders' meeting 28.04.2023 – first call
- List of candidates for the Health Italia Board of Statutory Auditors
- Explanatory report of the Board of Directors 28-29 April 2023
- Notice of call of the ordinary shareholders' meeting for 28-29 April 2023
- Assembly delegation 28-29 April 2023
- Minutes of the extraordinary shareholders' meeting 02.09.2023 – first call
- Minutes of ordinary shareholders' meeting 09.02.2023 – first call
- Notice of extraordinary and ordinary shareholders' meeting February 9-10, 2023
- Proxy to participate in the Health Italia assembly 9-10 February 2023
- Explanatory report Board of directors 9-10 February 2023
- GBC - AG - Research Report (update) 09 November 2023 - EN
- GBC - AG - Research Report (update) 09 November 2023 - DE
- Banca Profilo - Health Italia company update - 27 September 2023
- GBC - AG - Research Report Initial Coverage 29 august 2023 - DE
- GBC - AG - Research Report Initial Coverage 29 august 2023 - EN
- Banca Profilo - Health Italia Initial Coverage - 04 august 2023
- Mediobanca - Well positioned to deliver healthy growth - 05 October 2021
- Mediobanca - Looking to keep the growth path found in 2020 - 09 June 2021
- Mediobanca - Profitability step-up needed to unlock upside - 10 July 2020
- Mediobanca - Moving further steps in nutraceutics - 7 Nov 2019
- Equity Research - FY18 Update - 4 Oct 2019
- Equity Research - H1 2018 Update - 11 Dic 2018
- Mediobanca - Initiation of Coverage - 28 Feb 2018
- Equity Research - Initiation of Coverage - 23 Mag 2017
- Equity Research - IPO - Integrated Health Plans and Services - 24 Nov 2016
- Health Italia consolidated half-yearly financial statements as of 06.30.2023
- Health Italia consolidated half-year financial statements at 30.06.2022
- Health Italia consolidated half-year financial statements at 30.06.2021
- Consolidated half-yearly financial report as of June 30, 2020 with KPMG report
- Consolidated half-yearly financial report as of June 30, 2019 with KPMG report
- Interim Consolidated Financial Statements at 30/06/2018 with KPMG report
- Consolidated Interim Financial Statements at 30/06/2018
- Consolidated Half Year Report at 30/06/2018
- Consolidated Half Year Report at 30/06/2017
- Interim consolidated financial statements at 30/06/2016
- Financial statements and consolidated financial statements as at 31/12/2022 with reports by KPMG
- Financial statements and consolidated financial statements as at 31/12/2021 with reports by KPMG
- Financial statements and consolidated financial statements as at 31/12/2020 with reports by KPMG
- Financial statements and consolidated financial statements as at 31/12/2019 with KPMG reports
- Consolidated financial statements as at 31/12/2018 with KPMG report
- Consolidated financial statements as at 31/12/2018
- Financial statements as at 31/12/2018 with KPMG report
- Financial statements as at 31/12/2018
- Consolidated financial statement 31/12/2017
- Financial statement 31/12/2017
- Consolidated Financial Statements at 31/12/2016
- Financial statements at 31/12/2016
- Aggregate balance sheet at 31/12/2015
DATE | EVENTS |
---|---|
March 6, 2023 | Board of Directors - examination of the main preliminary consolidated results as at 31 December 2022 |
29 March 2023 | Board of Directors - approval of the draft financial statements and consolidated financial statements as at 31 December 2022 |
3 April 2023 | Health Italia at the “Spring Investor Conference” organized by Banca Profilo |
April 28, 2023 | Shareholders' meeting - approval of the financial statements and presentation of the consolidated financial statements as at 31 December 2022 |
May 18, 2023 | Board of Directors - examination of additional periodic information as of March 31, 2023 |
June 8, 2023 | Health Italia at the "Iberian Midcap Digital Event 2023" organized by Banca Profilo |
June 13, 2023 | Health Italia at the "Geneva Spring Midcap Event 2023" organized by Banca Profilo |
July 13, 2023 | Board of Directors - approval of the 2023-2026 Business Plan |
September 14, 2023 | Health Italia participates in the “Autumn Investor Conference” organized by Banca Profilo |
September 21, 2023 | Board of Directors - approval of the half-yearly report as of 30 June 2023 |
October 31, 2023 | Health Italia at the "Frankfurt Autumn Midcap Event" organized by CF&B Communication |
15/16 November 2023 | Health Italia at the “Münchner Kapitalmarkt Konferenz” organized by GBC Ag |
17 November 2023 | Board of Directors - examination of additional periodic information as of 30 September 2023 |
Livia Foglia
investor@healthitalia.itSpecialist

Euronext Growth Advisor

Corporate Broker

Auditor

Legal Advisor

Legal Advisor

Investor e Media Relations

Corporate Communications

Admission document
- are resident in Italy and who are not domiciled or in any case currently staying in the United States, Australia, Japan, Canada or any other country where the circulation of the Admission Document and/or of any such information that requires the approval of the local authorities or is in violation of local rules or regulations (“Other Countries”);
- they are not a "U.S. Person" as defined in Regulation S of the United States Securities Act of 1933, as subsequently amended.
Any "U.S. Person" as defined in the aforementioned paragraph is precluded from any access to this section of the Website, temporary or permanent download and saving of the Admission Document or any other information contained in this section of the Website. The information contained in this section of the website cannot be copied or forwarded. For no reason and under no circumstances, are you allowed to circulate, directly or through third parties, the Admission Document and any other information contained in this section of the website outside of Italy, particularly in the United States, Australia, Japan, Canada or Other Countries, or distribute the Admission Document to non-resident Italian citizens.
Regulation S of the United States Securities Act of 1933, as subsequently amended, defines a "U.S. Person" as:
- any physical person residing in the United States;
- "partnerships" and "corporations" established and organized according to the law in force in the United States;
- any property whose administrators or managers are a "U.S. Person";
- trusts whose trustee is a "U.S. Person";
- any agency, branch or subsidiary of a subject having its headquarters in the United States;
- non-discretionary accounts;
- other similar accounts (except properties or trusts), managed or administered confidentially on behalf of or for the benefit of a "U.S. Person";
- "partnerships" and "corporations" if (i) set up and organised according to the laws of any foreign jurisdiction; and (ii) constituted by a "U.S. Person" with the principal aim of investing in unlisted securities under the United States Securities Act of 1933, as subsequently amended, unless they are constituted or organized and owned by accredited investors (as defined in Rule 501 (a) of United States Securities Act of 1933) that are not natural persons, properties or trusts
To access this section of the website, the Admission Document and any other information contained in the following pages, I declare under my sole responsibility that I am resident in Italy and not domiciled or presently staying in the United States, Australia, Japan, Canada or Other Countries and that I am not a "U.S. Person" as defined in Regulation S of the United States Securities Act of 1933, as subsequently amended.
I confirm I have read and agree to the above Terms and Conditions
Health is the greatest strength of a civilised people
Keep in touch with us
Enter your email here to receive news from the world of Health Italia